MarketCap
Facebook
X
TelegramMediWound Ltd. Current Ratio 2011-2026 | MDWD
Annual Current Ratio MediWound Ltd.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 3.17 | 3.43 | 6.68 | 7.64 | 6.25 | 9.67 | 17.6 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.6 | 3.17 | 7.77 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
28.7 | - | 1052.0 % | $ 415 M |  USA |
 |
Aeterna Zentaris
AEZS
|
1.6 | - | 5.93 % | $ 314 M |  Canada |
 |
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | USA |
 |
I-Mab
IMAB
|
8.96 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
0.922 | - | 2.54 % | $ 160 B |  France |
 |
Aileron Therapeutics
ALRN
|
7.98 | - | 10.36 % | $ 9.8 M | USA |
 |
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M | France |
 |
Ascendis Pharma A/S
ASND
|
0.889 | $ 215.54 | -1.16 % | $ 5 B |  Danmark |
 |
Midatech Pharma plc
MTP
|
2.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.94 | $ 19.23 | - | $ 899 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.79 | - | - | $ 26.5 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
8.13 | $ 8.18 | -2.97 % | $ 109 M | USA |
 |
CytomX Therapeutics
CTMX
|
2.88 | $ 4.24 | -4.93 % | $ 585 M | USA |
 |
AgeX Therapeutics
AGE
|
1.81 | - | -10.17 % | $ 12.2 K | USA |
 |
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
13.4 | - | 4.01 % | $ 150 M | Canada |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - |  Russia |
 |
Eton Pharmaceuticals
ETON
|
1.4 | $ 22.97 | -3.53 % | $ 618 M | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
3.57 | $ 0.71 | 17.15 % | $ 8.13 M |  Israel |
 |
Fortress Biotech
FBIO
|
0.989 | $ 2.92 | -2.01 % | $ 60.7 M | USA |
 |
Adverum Biotechnologies
ADVM
|
1.65 | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
0.41 | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
5.93 | - | -9.65 % | $ 45.9 M | USA |
 |
Exelixis
EXEL
|
4.16 | $ 41.57 | 0.39 % | $ 11.3 B | USA |
 |
Avenue Therapeutics
ATXI
|
3.27 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
2.2 | $ 1.32 | -5.71 % | $ 337 M | Britain |
 |
Ayala Pharmaceuticals
AYLA
|
6.43 | - | - | $ 7.46 M | Israel |
 |
ChemoCentryx
CCXI
|
3.05 | - | - | $ 3.74 B | USA |
 |
Genmab A/S
GMAB
|
15 | $ 25.81 | 0.51 % | $ 16.6 B | Danmark |
 |
Aytu BioScience
AYTU
|
1.47 | $ 2.65 | 0.76 % | $ 16.6 M | USA |
 |
Grifols, S.A.
GRFS
|
1.67 | $ 7.6 | -1.17 % | $ 6.83 B |  Spain |
 |
Halozyme Therapeutics
HALO
|
1.02 | $ 62.04 | -1.3 % | $ 7.43 B | USA |
 |
Atreca
BCEL
|
2.02 | - | -11.76 % | $ 5.79 M | USA |
 |
BioDelivery Sciences International
BDSI
|
2.37 | - | -4.8 % | $ 255 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
2.47 | - | - | $ 867 M | Germany |
 |
BeiGene, Ltd.
BGNE
|
2.14 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bellerophon Therapeutics
BLPH
|
1.47 | - | -74.18 % | $ 955 K | USA |
 |
Immatics N.V.
IMTX
|
2.45 | $ 9.2 | -3.26 % | $ 579 M | Germany |
 |
Incyte Corporation
INCY
|
3.89 | $ 90.62 | 0.19 % | $ 17.7 B | USA |
 |
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
5.24 | $ 4.31 | -2.49 % | $ 826 M | Canada |
 |
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | USA |
 |
Ionis Pharmaceuticals
IONS
|
1.16 | $ 69.68 | -1.57 % | $ 11.1 B | USA |
 |
AIkido Pharma
AIKI
|
6.48 | - | 1.93 % | $ 17.4 M | USA |
 |
Allakos
ALLK
|
3.26 | - | - | $ 28.6 M | USA |
 |
Brickell Biotech
BBI
|
5.28 | - | -5.38 % | $ 6.06 M | USA |